rs4351

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000789.4(ACE):​c.2912+990G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 152,128 control chromosomes in the GnomAD database, including 19,039 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 19039 hom., cov: 33)

Consequence

ACE
NM_000789.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.343

Publications

56 publications found
Variant links:
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
ACE Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • intracerebral hemorrhage
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.595 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACENM_000789.4 linkc.2912+990G>A intron_variant Intron 19 of 24 ENST00000290866.10 NP_000780.1 P12821-1B4DKH4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACEENST00000290866.10 linkc.2912+990G>A intron_variant Intron 19 of 24 1 NM_000789.4 ENSP00000290866.4 P12821-1
ENSG00000264813ENST00000577647.2 linkn.1190+990G>A intron_variant Intron 8 of 30 2 ENSP00000464149.1 F6X3S4

Frequencies

GnomAD3 genomes
AF:
0.498
AC:
75749
AN:
152010
Hom.:
19004
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.528
Gnomad AMI
AF:
0.431
Gnomad AMR
AF:
0.534
Gnomad ASJ
AF:
0.368
Gnomad EAS
AF:
0.610
Gnomad SAS
AF:
0.612
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.473
Gnomad OTH
AF:
0.454
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.498
AC:
75826
AN:
152128
Hom.:
19039
Cov.:
33
AF XY:
0.500
AC XY:
37196
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.528
AC:
21902
AN:
41486
American (AMR)
AF:
0.534
AC:
8173
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.368
AC:
1279
AN:
3472
East Asian (EAS)
AF:
0.610
AC:
3161
AN:
5178
South Asian (SAS)
AF:
0.614
AC:
2961
AN:
4826
European-Finnish (FIN)
AF:
0.447
AC:
4729
AN:
10582
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.473
AC:
32149
AN:
67976
Other (OTH)
AF:
0.460
AC:
972
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1983
3967
5950
7934
9917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.491
Hom.:
29986
Bravo
AF:
0.500
Asia WGS
AF:
0.640
AC:
2225
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
4.8
DANN
Benign
0.64
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4351; hg19: chr17-61569732; API